Page last updated: 2024-08-23

etoposide and Androblastoma

etoposide has been researched along with Androblastoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhat, RA; Chia, YN; Lim, YK; Yam, KL1
Fujimoto, A; Ishihara, O; Itoyama, S; Kinoshita, K; Saitou, M; Takeda, S1
Burke, TW; Gershenson, DM; Levenback, C; Matthews, CM; Morris, M; Wharton, JT1
Deppe, G; Tomlinson, MW; Treadwell, MC1

Reviews

1 review(s) available for etoposide and Androblastoma

ArticleYear
Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy.
    European journal of gynaecological oncology, 1997, Volume: 18, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Sertoli-Leydig Cell Tumor

1997

Trials

1 trial(s) available for etoposide and Androblastoma

ArticleYear
Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.
    Obstetrics and gynecology, 1996, Volume: 87, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulosa Cell Tumor; Humans; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Prospective Studies; Sertoli-Leydig Cell Tumor; Sex Cord-Gonadal Stromal Tumors; Survival Rate

1996

Other Studies

2 other study(ies) available for etoposide and Androblastoma

ArticleYear
Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database.
    The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Ovarian Neoplasms; Ovariectomy; Prognosis; Retrospective Studies; Sertoli-Leydig Cell Tumor; Treatment Outcome

2013
[A case of ovarian malignant Sertoli-Leidig cell tumor treated with CBDCA, etoposide and epirubicin chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Remission Induction; Sertoli-Leydig Cell Tumor

1995